According to MarketsandMarketstm, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%. Browse 690 market data Tables and ...
According to MarketsandMarkets™, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%.
The SureScan Microarray Scanner is a key component of Agilent’s complete microarray solution. With improved feature resolution, it delivers exceptional flexibility to analyze any microarray ...
Raphas, a mass-production platform company specializing in microneedle technology, has teamed up with Japanese electronics ...
Morning Overview on MSN
A new compound from ETH Zurich cut nerve-cell loss in mice with Alzheimer’s
Scientists at ETH Zurich have identified a compound that sharply reduced nerve-cell death in mice engineered to develop ...
DelveInsight's DNA Diagnostics Market Insights report provides the current and forecast market analysis, individual leading ...
Colorectal cancer (CRC) remains one of the most heterogeneous malignancies, with substantial variability in molecular ...
Morning Overview on MSN
Scientists traced why H5N1 bird flu hits cows’ udders instead of their lungs
Scientists have now traced why the H5N1 bird flu virus that jumped into U.S. dairy herds keeps turning up in cows’ udders and ...
AI has been used to develop a universal vaccine that could protect against multiple coronaviruses. The successful Phase 1 ...
JenaValve data backs Trilogy TAVR in AR, LVAD patients July 1, 2026 By Sean Whooley JenaValve today announced new clinical findings for its Trilogy TAVR system, shared last week at the New York Valves ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results